| Meta-analysis summary statistics for associations meeting genome-wide significance | |||||||
|---|---|---|---|---|---|---|---|
| Lead SNP | Biochemicals | EA/OA | Ntotal | EAF | Effect (SE) | Pmeta | Details |
| rs4784054 | phenyllactate (PLA) | A/G | 5702 | 0.11 | 0.035 (0.004) | 2.31·10-21 | show |
EA = effect allele; OA = other allele; EAF = frequency of effect allele;
| Summary of biological annotations | |
|---|---|
| SNP | rs4784054 |
| Chromosomal location | Chr16: 57,333,815 (16q21) |
| Gene (distance) | GOT2 (8,069) |
| Predicted causal gene | GOT2 |
| Gene/protein classification | - |
| Metabolite (Pathway) | phenyllactate (PLA) (Phenylalanine & tyrosine metabolism; Amino acid) |
| Biochemical locus-metabolite relationship | GOT2 encodes mitochondrial glutamic-oxaloacetic transaminase 2 which can take each of the aromatic amino acids as substrates. [4623131]. In particular, GOT2 catalyzes the conversion of phenylalanine to phenylpyruvate which is then converted to phenyllactate. |
| eQTL associations | - |
| Medical information | |
|---|---|
| Complex trait associations | - |
| Known metabolite associations | - |
| Inborn error of metabolism | - |
| Pharmacological information | |
|---|---|
| ChEMBL ID | - |
| Drug information | - |
| Locus information for top associated metabolite | |
|---|---|
HapMap2 imputation![]() | 1KGP imputation![]() |








